124 related articles for article (PubMed ID: 17233704)
1. Total cholesterol levels and the risk of mild cognitive impairment and Alzheimer's disease.
Panza F; Capurso C; D'Introno A; Colacicco AM; De Candia D; Capurso A; Solfrizzi V
J Am Geriatr Soc; 2007 Jan; 55(1):133-5. PubMed ID: 17233704
[No Abstract] [Full Text] [Related]
2. Involvement of cholesterol in the pathogenesis of Alzheimer's disease: role of statins.
Pregelj P
Psychiatr Danub; 2008 Jun; 20(2):162-7. PubMed ID: 18587285
[TBL] [Abstract][Full Text] [Related]
3. Statins, incident Alzheimer disease, change in cognitive function, and neuropathology.
Pappolla MA
Neurology; 2008 Dec; 71(24):2020; author reply 2020-1. PubMed ID: 19086266
[No Abstract] [Full Text] [Related]
4. Relation between cholesterol levels, statins and Alzheimer's disease in the human population.
Austen B; Christodoulou G; Terry JE
J Nutr Health Aging; 2002; 6(6):377-82. PubMed ID: 12459888
[TBL] [Abstract][Full Text] [Related]
5. [Alzheimer's disease and treatment of vascular risk factors].
de Leeuw FE; van Norden AG; van der Flier WM; Olde Rikkert MG; Scheltens P
Ned Tijdschr Geneeskd; 2005 Dec; 149(51):2844-9. PubMed ID: 16398165
[TBL] [Abstract][Full Text] [Related]
6. A novel reciprocal and biphasic relationship between membrane cholesterol and beta-secretase activity in SH-SY5Y cells and in human platelets.
Liu WW; Todd S; Coulson DT; Irvine GB; Passmore AP; McGuinness B; McConville M; Craig D; Johnston JA
J Neurochem; 2009 Jan; 108(2):341-9. PubMed ID: 19094065
[TBL] [Abstract][Full Text] [Related]
7. The influence of age on the association between cholesterol and cognitive function.
van Vliet P; van de Water W; de Craen AJ; Westendorp RG
Exp Gerontol; 2009; 44(1-2):112-22. PubMed ID: 18579327
[TBL] [Abstract][Full Text] [Related]
8. Statin therapy in Alzheimer's disease.
Kivipelto M; Solomon A; Winblad B
Lancet Neurol; 2005 Sep; 4(9):521-2. PubMed ID: 16109358
[No Abstract] [Full Text] [Related]
9. Balanced report on lipoprotein metabolism and the association with Alzheimer's disease and related disorders(ADRD).
Trenkle D
J Clin Lipidol; 2010; 4(3):196; author reply 196-7. PubMed ID: 21122653
[No Abstract] [Full Text] [Related]
10. Serum total cholesterol as a biomarker for Alzheimer's disease: mid-life or late-life determinations?
Panza F; Capurso C; D'Introno A; Colacicco AM; Vasquez F; Pistoia G; Capurso A; Solfrizzi V
Exp Gerontol; 2006 Sep; 41(9):805-6. PubMed ID: 16843631
[No Abstract] [Full Text] [Related]
11. Bioplex analysis of plasma cytokines in Alzheimer's disease and mild cognitive impairment.
Lee KS; Chung JH; Lee KH; Shin MJ; Oh BH; Hong CH
Immunol Lett; 2008 Dec; 121(2):105-9. PubMed ID: 18930766
[TBL] [Abstract][Full Text] [Related]
12. The hydroxy-methyl-glutaryl CoA reductase promoter polymorphism is associated with Alzheimer's risk and cognitive deterioration.
Porcellini E; Calabrese E; Guerini F; Govoni M; Chiappelli M; Tumini E; Morgan K; Chappell S; Kalsheker N; Franceschi M; Licastro F
Neurosci Lett; 2007 Apr; 416(1):66-70. PubMed ID: 17284348
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular disease risk factors and cognitive impairment.
Nash DT; Fillit H
Am J Cardiol; 2006 Apr; 97(8):1262-5. PubMed ID: 16616038
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol-modifying strategies for Alzheimer's disease.
Solomon A; Kivipelto M
Expert Rev Neurother; 2009 May; 9(5):695-709. PubMed ID: 19402779
[TBL] [Abstract][Full Text] [Related]
15. The imperative for disease modifying treatments in Alzheimer's disease.
Gallagher D; Mhaolain AN; Lawlor B
Ir Med J; 2009 Feb; 102(2):37-8. PubMed ID: 19405314
[No Abstract] [Full Text] [Related]
16. Alzheimer's disease, amnestic mild cognitive impairment, and age-associated memory impairment: current understanding and progress toward integrative prevention.
Kidd PM
Altern Med Rev; 2008 Jun; 13(2):85-115. PubMed ID: 18590347
[TBL] [Abstract][Full Text] [Related]
17. [Vascular risk factors and Alzheimer's disease].
Regalado Doña PJ; Azpiazu Artigas P; Sánchez Guerra ML; Almenar Monfort C
Rev Esp Geriatr Gerontol; 2009; 44(2):98-105. PubMed ID: 19268394
[TBL] [Abstract][Full Text] [Related]
18. Bioavailable testosterone is associated with a reduced risk of amnestic mild cognitive impairment in older men.
Chu LW; Tam S; Lee PW; Wong RL; Yik PY; Tsui W; Song Y; Cheung BM; Morley JE; Lam KS
Clin Endocrinol (Oxf); 2008 Apr; 68(4):589-98. PubMed ID: 17973937
[TBL] [Abstract][Full Text] [Related]
19. Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins.
Casserly I; Topol E
Lancet; 2004 Apr; 363(9415):1139-46. PubMed ID: 15064035
[TBL] [Abstract][Full Text] [Related]
20. The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study.
Chiu CC; Su KP; Cheng TC; Liu HC; Chang CJ; Dewey ME; Stewart R; Huang SY
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1538-44. PubMed ID: 18573585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
